Although SGLT2 inhibitors are standard-of-care treatments for CKD, type 2 diabetes, and heart failure (HF), the drugs are underutilized in clinical practice.
Individual patients may have substantial differences in their eGFRcr and eGFRcys for estimating kidney function, which has prognostic implications.
Expert discusses how the prevalence of chronic kidney disease (CKD), as reflected by decreased estimated glomerular ...
HOUSTON -- Two commonly used kidney function tests had a large degree of disagreement and were linked with serious health outcomes in patients with chronic kidney disease (CKD), according to a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback